Dow Down 1.40% Nasdaq Down 1.59%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
167.20 Up 1.38(0.83%) Oct 1, 4:00PM EDT
|After Hours : 167.20 0.00 (0.00%) Oct 1, 4:56PM EDT
Prev Close:165.82
Open:166.86
Bid:156.13 x 100
Ask:176.00 x 100
1y Target Est:198.57
Beta:0.62
Earnings Date:Oct 22 - Oct 27 (Est.)
Day's Range:164.94 - 167.67
52wk Range:100.89 - 185.43
Volume:1,248,097
Avg Vol (3m):1,112,260
Market Cap:33.07B
P/E (ttm):83.81
EPS (ttm):2.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
ALXNUp 0.83%33.07B
AMGNDown 1.17%105.45B
BAXDown 0.36%38.74B

Key Statistics

Forward P/E (1 yr):29.03
P/S (ttm):17.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :5.01
Quarterly EPS Est (Sep-14) :1.16
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):1.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback